UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039901
Receipt number R000045507
Scientific Title Long term flaxseed consumption for cognitive function in the elderly
Date of disclosure of the study information 2020/03/24
Last modified on 2022/03/25 15:55:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long term flaxseed consumption for cognitive function in the elderly

Acronym

Long term flaxseed consumption for cognitive function in the elderly

Scientific Title

Long term flaxseed consumption for cognitive function in the elderly

Scientific Title:Acronym

Long term flaxseed consumption for cognitive function in the elderly

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of oral intake of flaxseed oil which is rich in alpha-linolenic acid, and classified as the omega-3 fatty acids on cognitive function of healthy subjects.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Before and after 6 and 12 weeks of Flaxseed oil consumption cognitive function will be evaluated.

Key secondary outcomes

Before and after 6 and 12 weeks of flaxseed oil consumption, the following items will be evaluated:
Food frequency
Depression
QOL
Physical conditions


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Participants in flaxseed oil group are asked to take a flaxseed oil containing package with no prints.
Flaxseed oil 3.7g/package, 1package/day for 12 weeks.

Interventions/Control_2

Corn oil is used as placebo. Corn oil containing package with no prints is used.
corn oil 3.7g/package,1package/day for 12 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Mini Mental State Examination (MMSE) more than 27points
2.Clinical Dementia Rating (CDR) 0point
3.65-80 years old when admitted
4.Right handed
5.Signed informed consent

Key exclusion criteria

1.Severe past history of brain, psychological and internal disease
2.Severe visual and hearing disturbance
3.Excessive slimming/obesity (BMI less than 17, more than 30)
4.History of long term flaxseed oil consumption
5.Frequent fish intake
6.Mental illness or psychiatric symptoms and are judged to be difficult to participate in the study by physician
7.Any participant who is judged not suitable for this study by physician

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Ryuta
Middle name
Last name Kawashima

Organization

Tohoku University

Division name

Institute of Development, Aging and Cancer

Zip code

9808575

Address

4-1 Seiryocho, Aobaku, Sendai, Miyagi

TEL

022-717-7988

Email

ryuta.kawashima.a6@tohoku.ac.jp


Public contact

Name of contact person

1st name Toshimi
Middle name
Last name Ogawa

Organization

Tohoku University

Division name

Institute of Development, Aging and Cancer

Zip code

9808575

Address

4-1 Seiryocho, Aobaku, Sendai, Miyagi

TEL

022-717-7988

Homepage URL


Email

toshimi.ogawa.e6@tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

NIPPON FLOUR MILLS Co.,Ltd

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Graduate School of Medicine

Address

2-1 Seiryocho, Aobaku, Sendai, Miyagi

Tel

022-717-8007

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

60

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 03 Month 23 Day

Date of IRB

2020 Year 04 Month 30 Day

Anticipated trial start date

2020 Year 09 Month 01 Day

Last follow-up date

2021 Year 10 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 03 Month 22 Day

Last modified on

2022 Year 03 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045507